StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) income statement

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.90−0.01 (-1.22%)

Close on Nov 20, 2026Market cap $8.10MP/E –Yield –

See a number that looks wrong?